2014
DOI: 10.1002/ajmg.a.36662
|View full text |Cite
|
Sign up to set email alerts
|

Severe sex differentiation disorder in a boy with a 3.8 Mb 10q25.3–q26.12 microdeletion encompassing EMX2

Abstract: The molecular basis of male disorders of sex development (DSD) remains unexplained in a large number of cases. EMX2 has been proposed to play a role in the masculinization process for the past two decades, but formal evidence for this causal role is scarce. The aim of this study is to yield additional support to this hypothesis by reporting on a male patient who presented with 46,XY DSD, a single kidney, intellectual disability, and the smallest microdeletion including EMX2 reported to date. EMX2 haploinsuffic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 18 publications
(21 reference statements)
2
23
0
Order By: Relevance
“…Emx2 expression is stimulated by Wnt and Bmp signalling in nervous system development (Theil, Aydin, Koch, Grotewold, & Ruther, ) and it is repressed by HOXA10 during development of the endometrium of mice and humans (Daftary & Taylor, ; Troy, Daftary, Bagot, & Taylor, ) but very little is known about the control of EMX2 in the developing gonad. In patients, deletions encompassing EMX2 cause 46,XY DSD ranging from hypospadias to gonadal dysgenesis (Piard et al., ), confirming its role in human gonadal development (MIM 269160). In human development, EMX2 and CBX2 are simultaneously expressed in the gonadal anlage at 7 weeks of gestation, i.e.…”
Section: Discussionmentioning
confidence: 88%
“…Emx2 expression is stimulated by Wnt and Bmp signalling in nervous system development (Theil, Aydin, Koch, Grotewold, & Ruther, ) and it is repressed by HOXA10 during development of the endometrium of mice and humans (Daftary & Taylor, ; Troy, Daftary, Bagot, & Taylor, ) but very little is known about the control of EMX2 in the developing gonad. In patients, deletions encompassing EMX2 cause 46,XY DSD ranging from hypospadias to gonadal dysgenesis (Piard et al., ), confirming its role in human gonadal development (MIM 269160). In human development, EMX2 and CBX2 are simultaneously expressed in the gonadal anlage at 7 weeks of gestation, i.e.…”
Section: Discussionmentioning
confidence: 88%
“…( AKR1C2/AKR1C4 ) [Fluck et al, 2011] • ww domain-containing oxidoreductase ( WWOX ) [White et al, 2012] • zinc finger protein, multiple 2 ( ZFPM2 ) or friend of GATA2 ( FOG2 ) [Bashamboo et al, 2014] • empty spiracles, drosophila, 2, homolog of ( EMX2 ) [Piard et al, 2014] • hedgehog acyltransferase ( HHAT ) [Callier et al, 2014] • fibroblast growth factor receptor 2 ( FGFR2 ) [BagheriFam et al, 2015] Next-generation sequencing techniques allow the description of new candidate genes involved in regulating sex development and will also verify the hypothesis of a possible di-or oligenic origin for different sex development in some patients.…”
Section: From Cytogenetic To Molecular Diagnosismentioning
confidence: 99%
“…The kidneys, ureters, gonads, and genital tracts are completely absent in Emx2 À/À mutant mice, whereas the adrenal glands and bladder develop normally. Recently, Piard et al (2014) diagnosed a male patient who presented with 46,XY DSD, a single kidney, intellectual disability, and the smallest microdeletion including EMX2 reported to date. EMX2 haploinsufficiency in human is likely to explain the masculinization defect observed, similar to what has been described in mice.…”
Section: Emx2mentioning
confidence: 99%
“…MAPK signaling in gonad development has been recently demonstrated by the identification of a mutation in Map3k4 in mouse, resulting in XY individuals with male-to-female sex reversal (Piard et al 2014). More importantly, a related MAP3K4 gene, MAP3K1, has been identified in humans as a novel gene causing 46,XY gonadal dysgenesis (Loke et al 2014;Muzio et al 2005).…”
Section: Map Kinasesmentioning
confidence: 99%